The White House is weighingwhether to temporarily lift intellectual property protections on Covid-19 vaccines and treatments.
The move would allow other countries to replicate existing vaccines.
Concerns have grown about the fact that the U.S. and a handful of other wealthy countries hold the right to a disproportionate amount of the global supply.